Pancreatic Cancer

Namodenoson was well tolerated in a phase 2a study of advanced pancreatic cancer, with one-third of patients alive at data cutoff.

The U.S. Food and Drug Administration has approved a new treatment for adults with locally advanced pancreatic cancer.

Dr. Meredith Pelster sat down for an interview with CURE to discuss new data surrounding new treatment outcomes for metastatic pancreatic cancer.

Ampligen and Imfinzi combination therapy demonstrated clinical activity for patients with metastatic pancreatic cancer.

Dr. Benjamin Jon Golas outlines pancreatic cancer care, including surgery, chemotherapy, radiation and emerging targeted therapies at specialized centers.

A potential new approach to treating advanced pancreatic cancer has shown benefit for patients, according to Dr. Eileen M. O'Reilly.

Dan, diagnosed with stage 4 pancreatic cancer, shares his journey to remission and insights on clinical trials and patient advocacy.

Patients with severe pancreatic cancer pain experienced consistent improvements in functionality and quality of life following targeted ablation therapy.

Breaking down the rare gastrointestinal cancer, from diagnosis to treatment.

Dr. Suneel Kamath sat down for Pancreatic Cancer Awareness Month to discuss advances in treatment and the importance of raising awareness for this disease.

In recognition of Pancreatic Cancer Awareness Month, Dr. Suneel Kamath sat down for an interview where he shared his insights on this aggressive disease.

In honor of Pancreatic Cancer Awareness Month, we spoke with Dr. Rosario Ligresti about rising rates of the disease in younger adults and more.

What are we supposed to do to be a “true” friend to someone who is facing cancer?

Each year, the PanCAN Scientific Summit brings together some of the brightest minds in pancreatic cancer research.

VCN-01 plus standard chemotherapy and Abraxane proved safe and effective for patients with metastatic pancreatic cancer.

Artificial intelligence (AI) is revolutionizing the way cancer is studied and treated.

For patients with pancreatic cancer, this is a guide to the basics you need to know about this disease.

My cancer journey began with a surgical oncologist who extracted my one-inch pancreatic tumor, taking with it the top third of my pancreas.

Utidelone, previously received orphan drug designation from the FDA for the treatment of breast cancer brain metastases and gastric cancer.

Pancreatic cancer remains one of the deadliest cancers because it is often detected at an advanced stage when treatment options are limited.

Among patients with pancreatic cancer, the vaccine ELI-002 7P elicited strong mKRAS-specific T cell responses in approximately 99% of patients.

As a 12-year pancreatic cancer survivor, I share my journey through diagnosis, treatment and survival, hoping my story inspires others to act beyond slogans.

Cancer leaves deep emotional scars long after treatment ends, but for many survivors, honest, unfiltered writing can be a powerful path to healing.

Daraxonrasib has received breakthrough therapy designation from the FDA for KRAS G12+, previously treated, metastatic pancreatic ductal adenocarcinoma.

Tripp Razor highlights the disproportionately high pancreatic cancer risk among Black Americans and the systemic disparities they face in access to care.